FAYE M JOHNSON to Antineoplastic Agents, Immunological
This is a "connection" page, showing publications FAYE M JOHNSON has written about Antineoplastic Agents, Immunological.
Connection Strength
0.184
-
ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response. J Immunother Cancer. 2022 02; 10(2).
Score: 0.102
-
Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients With Incurable Human Papillomavirus 16-Related Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 2019 01 01; 5(1):67-73.
Score: 0.082